Рецидивы и края резекции R1 в зависимости от гистологических характеристик и молекулярно-биологических типов рака молочной железы

Каприн А.Д., Старинский В.В., Шахзадова А.О. Состояние онкологической помощи населению России в 2019 г. Москва, 2020 [Kaprin AD, Starinsky VV, Shakhzadova AO. The state of oncological care for the population of Russia in 2019. Moscow, 2020 (In Russ.)].

Corradini AG, Cremonini A, Cattani MG et al. Which type of cancer is detected in breast screening programs? Review of the literature with focus on the most frequent histological features // Pathologica. 2021;113(2):85–94. doi:10.32074/1591-951X-123

Desmedt Ch, Zoppoli G, Sotiriou Ch, Salgado R. Transcriptomic and genomic features of invasive lobular breast cancer // Seminars in Cancer Biology. 2017;44:98–105. doi:10.1016/j.semcancer.2017.03.007

Adachi Y, Ishiguro J, Kotani H et al. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma // BMC Cancer. 2016;16:248. doi:10.1186/s12885-016-2275-4

Chamalidou C, Fohlin H, Albertsson P et al. Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up // Breast. 2021;59:294–300. doi:10.1016/j.breast.2021.07.011

Lu K, Wang X, Zhang W et al. Clinicopathological and genomic features of breast mucinous carcinoma // Breast. 2020;53:130–137. doi:10.1016/j.breast.2020.07.010.

Sharma P. Biology and Management of Patients With Triple-Negative Breast Cancer // The Oncologist. 2016;21(Issue 9):1050–1062 doi.org/10.1634/theoncologist.2016-0067

Zein DE, Hughes M, Kumar Sh et al. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature // Clin Breast Cancer. 2017;17(5):382–391. doi:10.1016/j.clbc.2017.04.009

Ignatov A, Eggemann H, Burger E, Ignatov T. Patterns of breast cancer relapse in accordance to biological subtype // J Cancer Res Clin Oncol. 2018;144(7):1347–1355. doi:10.1007/s00432-018-2644-2

Moossdorff M, Vane MLG, Van Nijnatten TJA et al. Conditional local recurrence risk: the effect of event-free years in different subtypes of breast cancer // Breast Cancer Res Treat. 2021;186(3):863–870. doi:10.1007/s10549-020-06040-3

Quan ML, Paszat LF, Fernandes KA et al. The effect of surgery type on survival and recurrence in very young women with breast cancer // J Surg Oncol. 2017;115(2):122–130. doi:10.1002/jso.24489

André C, Holsti C, Svenner A et al. Recurrence and survival after standard versus oncoplastic breast-conserving surgery for breast cancer // BJS Open. 2021;5(Issue 1). doi:10.1093/bjsopen/zraa013

Pilewskie M, Morrow M. Margins in breast cancer: How much is enough? // Cancer. 2018;124(7):1335–1341. doi:10.1002/cncr.31221

Ozturk A, Ilgun S, Ucuncu M et al. The effect of multifocal and multicentric tumours on local recurrence and survival outcomes in breast cancer // J BUON. 2021;26(1):196–203.

Djordjevic-Jovanovic L, Karanikolic A, Bojic T et al. Characteristics and outcomes of patients with multifocal/multicentric and unifocal breast cancer // J BUON. 2017;22(3):652–657.

Cowend M, Jacquemier J, Nonvenaeghel G. Local and distant recurrence after conservative management of «very low risk» breast cancer are dependent events: a 10 year follow–up // Int. J. Rad. Oncol, Phys. 1998;41(5):801–807. doi: 10.1016/s0360-3016 (98) 00144-8

Криворотько П.В., Семиглазов В.В., Канаев С.В и др. Риск местного рецидива после органосохраняющих операций на молочной железе // Вопросы онкологии. 2011;57(4):627–635 [Krivorotko PV, Semiglazov VV, Kanaev SV et al. The risk of local relapse after organ-preserving operations on the mammary gland // Voprosy onkologii. 2011;57(4):627–635 (In Russ.)].

Надыров Э.А. Прогностическое значение клинико-морфологических и иммуногистохимических показателей при раке молочной железы // Проблемы здоровья и экологии. 2008;18(4):56–59 [Nadyrov E.A. Prognostic value of clinical-morphological and immunohistochemical parameters in breast cancer // Problemy zdorovya i ecologii. 2008;18(4):56–59 (In Russ.)].

Bense RD, Qiu Si-Qi, Vries EGE et al. Considering the biology of late recurrences in selecting patients for extended endocrine therapy in breast cancer // Cancer Treat Rev. 2018;70:118–126. doi:10.1016/j.ctrv.2018.07.015

Leon-Ferre RA, Polley M-Y, Liu H et al. Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer // Breast Cancer Res Treat. 2018;167(1):89–99. doi:10.1007/s10549-017-4499-7